GELESIS HOLDINGS, INC.: Nasdaq/NYSE listing notice — NYSE warns Gelesis of non-compliance; average closing price below $1.00 for 30 days

GELESIS HOLDINGS, INC.

Received NYSE notice on Nov 2, 2022 that average closing price below $1.00 for 30 consecutive trading days, violating Section 802.01C.
Company has six-month cure period; can regain compliance if closing price ≥$1.00 on last trading day of month and 30-day average ≥$1.00.
Intends to consider all available alternatives to regain compliance; common stock continues trading under GLS during cure period.
Failure to cure could result in NYSE suspension and delisting procedures.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GELESIS HOLDINGS, INC. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

November 2, 2022, Gelesis Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the New York Stock Exchange (the “NYSE”) advising that because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period, it is not in compliance with Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”). The Company’s common stock will continue to be listed and traded on the NYSE, subject to the Company’s compliance with other NYSE continued listing standards. As required by Section 802.01C, the Company must not

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-22-022254

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.